Výsledky vyhledávání

Akademický článek

Acute response to the October 7th hostage release: rapid development and evaluation of the novel ReSPOND protocol implementation within a children’s hospital

Autor: Naama de la Fontaine, Tamar Silberg, Jörg M. Fegert, Shlomit Tsafrir, Hana Weisman, Noa Rubin, Moshe Ashkenazi, Nitsa Nacasch, Michael L. Polliack, Wendy Chen, Meirav Herman-Raz, Ronit Wachsberg-Lachmanovich, Liat Pessach-Gelblum, Amitai Ziv, Anat Moshkovitz, Noya Shilo, Yael Frenkel-Nir, Doron Gothelf, Itai M. Pessach

Publikováno v: Child and Adolescent Psychiatry and Mental Health, Vol 18, Iss 1, Pp 1-17 (2024)

Abstract Background The decision to allocate hospitals for the initial reception of hostages abducted on the October 7th Hamas attack introduced an array of unprecedented challenges. These challenges stemmed from a paucity of existing literature and

Externí odkaz: https://doaj.org/article/b83636c22ec74a4a9e061ac15fda24b2

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Autoimmune Neutropenia Associated With HHV-6 Virus Infection: A Case Report

Autor: Kobi Faierstein, Noya Shilo, Asaf Levartovsky, Roy Raphael, Amir Givon, Nancy Agmon-Levin, Haim Mayan

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

BackgroundAutoimmune neutropenia (AIN) is divided into primary and secondary forms. The former is more prevalent in children and is usually a self-limiting disease. Secondary AIN is more common in adults and often occurs in the setting of another aut

Externí odkaz: https://doaj.org/article/80de05d0e48a4a58bd34bed69ab3cf5b

Zobrazit plný text záznamu

Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19

Autor: Reut Kassif Lerner, Dor Lotan, Daniel Oren, Edward Itelman, Yuval Neeman, Shahar Dekel, Eyal Heller, Arsalan Abu-Much, Noya Shilo, Rami Gilead, Evyatar Hubara, Meir Mouallem, Yael Haviv, Alexander Kogan, Haim Mayan, Itai M Pessach

Publikováno v: Clin Med (Lond)

As the COVID-19 pandemic continues to evolve, different clinical manifestations are better understood and studied. These include various haematologic disorders that have been shown to be associated with increased morbidity and mortality. We studied t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6af3e483a2c0bb800034de3257f1f23
https://pubmed.ncbi.nlm.nih.gov/36507809

Zobrazit plný text záznamu

[ETHICAL CHALLENGES IN TREATING CRITICAL CORONAVIRUS PATIENTS: EXPERIENCE FROM THE SHEBA MEDICAL CENTER ON THE FIRST COVID-19 PANDEMIC OUTBREAK]

Autor: Noya, Shilo, Yael, Haviv-Yadid, Alexander, Kogan, Itay, Pessach, Amir, Sharon, Lior, Nave, Roy, Raphael, Nira, Abbo, Roza, Shuki, Reut, Kassif-Lerner, Meir, Mouallem, Haim, Mayan, Haim, Berkenstadt

Publikováno v: Harefuah. 160(11)

As the coronavirus pandemic emerged in late 2019, a task force was founded in the Sheba Medical Center and began preparing for the arrival of the pandemic to Israel. Several wards were put in charge of isolated COVID-19 patients. A new intensive care

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2caba821063e32782a5c7d45c1e870ce
https://pubmed.ncbi.nlm.nih.gov/34817134

Zobrazit plný text záznamu

Utilization of machine-learning models to accurately predict the risk for critical COVID-19

Autor: Yair Neuman, Shiraz Gefen-Halevi, Avi Epstein, Gad Segal, Ya’ara Gutman, Noya Shilo, Amit Tirosh, Asaf Biber, Itzchak Levy, Galia Rahav, Dan Assaf, Sharon Amit, Ronit Mor-Cohen

Publikováno v: Internal and Emergency Medicine

Among patients with Coronavirus disease (COVID-19), the ability to identify patients at risk for deterioration during their hospital stay is essential for effective patient allocation and management. To predict patient risk for critical COVID-19 base

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1f91637c2675cd717afd465b5c89bb

Zobrazit plný text záznamu

The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators

Autor: Lola Weiss, Valeria Voevoda-Dimenshtein, Avichai Shimoni, Evgenia Rosenberg, Jonathan Canaani, Michal Abraham, Amnon Peled, Hila Magen, Yaarit Sirovsky, Arnon Nagler, Olga Ostrovsky, Noya Shilo, Katia Beider, Michael Milyavsky, Hanna Bitner

Publikováno v: Biochemical pharmacology. 168

Although having promising anti-myeloma properties, the pan-histone deacetylase inhibitor (HDACi) panobinostat lacks therapeutic activity as a single agent. The aim of the current study was to elucidate the mechanisms underlying multiple myeloma (MM)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98533f2f17bdb27f1e83333a04a6e7aa
https://pubmed.ncbi.nlm.nih.gov/31325448

Zobrazit plný text záznamu

The mTOR Inhibitor Everolimus Overcomes CXCR4-Mediated Resistance to HDAC Inhibitor Panobinostat through Inhibition of p21 and Mitosis Regulators, Sensitizing MM Cells to DNA-Damaged Induced Apoptosis

Autor: Katia Beider, Valeria Voevoda, Hila Magen, Avichai Shimoni, Hanna Bitner, Olga Ostrovsky, Evgenia Rosenberg, Amnon Peled, Noya Shilo, Arnon Nagler, Michael Milyavsky, Merav Leiba

Publikováno v: Blood. 128:891-891

Introduction: Multiple myeloma (MM) is a neoplastic disorder that is characterized by clonal proliferation of plasma cells in the bone marrow (BM). Despite the initial efficacious treatment, MM patients often become refractory to common anti-MM drugs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae784f3b683257ad90e9bcad189dfa3a
https://doi.org/10.1182/blood.v128.22.891.891

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání